ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability. The great quarter was driven by high ...

ResMed Inc . (NYSE:RMD) reported its financial results for the second quarter of fiscal year 2025, exceeding analysts' expectations with an earnings per share (EPS) of $2.43, surpassing the forecasted ...

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading ... its cloud-based patient monitoring system, AirView, compared with the ...

ResMed (NYSE:RMD), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst ...

Workforce services provider System One has acquired the three-unit Tech USA Companies to support its focus on providing comprehensive staffing services to critical infrastructure, technology ...

The news: Respiratory health company ResMed has posted strong revenue growth and expanded margins across its global sleep and respiratory care businesses in the December quarter. The numbers: Revenue ...

but if they don’t happen and there are blanket tariffs that won’t affect ResMed, because we manufacture in Sydney, in Singapore or Atlanta,’’ he said. “One of our competitors selling in ...

(RTTNews) - Resmed Inc (RMD) revealed a profit for its second quarter that increased from last year and beat the Street estimates. The company's earnings totaled $344.6 million, or $2.34 per share.

The S9 Elite™ is a whisper quiet, elegant and comfortable therapy system for the treatment of Obstructive Sleep Apnoea (OSA). The S9 Elite provides Continuous Positive Airway Pressure (CPAP ...